Innova Captab Limited (NSE:INNOVACAP)

India · Delayed Price · Currency is INR

860.80

+10.40 (1.22%)

Jun 1, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Drugs and Pharmaceutical Products	16.30B	12.44B	10.81B	9.26B	8.01B
Drugs and Pharmaceutical Products Growth	31.06%	15.02%	16.72%	15.72%	94.94%
Total	16.30B	12.44B	10.81B	9.26B	8.01B
Total Growth	31.06%	15.02%	16.72%	15.72%	94.94%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	9.15B	8.32B	8.45B	7.23B
India Growth	9.96%	-1.47%	16.84%	95.52%
outside India	3.19B	2.45B	806.63M	767.81M
outside India Growth	30.49%	203.29%	5.06%	92.96%
Total	12.34B	10.77B	9.25B	8.00B
Total Growth	14.62%	16.38%	15.71%	95.27%

Source: S&P Global Market Intelligence.